Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.65% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DX
2026
Dynex Capital
DX
$3.23B
| $1.58M | ﹤0.01% |
132,000
+96,100
| +268% | +$1.15M |
|
2027
Solid Biosciences
SLDB
$972M
| $1.57M | ﹤0.01% |
277,564
+208,793
| +304% | +$1.87M |
|
|
CNTA
2028
DELISTED
Centessa Pharmaceuticals
CNTA
| $1.57M | ﹤0.01% |
173,700
-45,100
| -21% | -$428K |
|
2029
Cimpress
CMPR
$2.4B
| $1.57M | ﹤0.01% |
17,900
-12,700
| -42% | -$1.11M |
|
2030
iShares International Select Dividend ETF
IDV
$8.53B
| $1.57M | ﹤0.01% |
56,600
-70,500
| -55% | -$2M |
|
2031
Minerals Technologies
MTX
$2.25B
| $1.56M | ﹤0.01% |
+18,800
| New | +$1.49M |
|
2032
The RealReal
REAL
$1.36B
| $1.56M | ﹤0.01% |
+489,900
| New | +$1.81M |
|
2033
Northrim BanCorp
NRIM
$599M
| $1.56M | ﹤0.01% |
108,400
+23,200
| +27% | +$299K |
|
2034
Liberty Broadband Class A
LBRDA
$5.07B
| $1.56M | ﹤0.01% |
28,600
-1,200
| -4% | -$62.1K |
|
2035
Babcock & Wilcox
BW
$1.39B
| $1.56M | ﹤0.01% |
1,075,138
+82,100
| +8% | +$98.7K |
|
2036
Xtrackers S&P 500 ESG ETF
SNPE
$2.8B
| $1.56M | ﹤0.01% |
31,100
+4,900
| +19% | +$235K |
|
|
SPYU
2037
MAX S&P 500 4x Leveraged ETN
SPYU
$300M
| $1.55M | ﹤0.01% |
+73,800
| New | +$1.38M |
|
|
TBI
2038
Trueblue
TBI
$302M
| $1.55M | ﹤0.01% |
150,600
-95,800
| -39% | -$1.04M |
|
2039
Electromed
ELMD
$352M
| $1.55M | ﹤0.01% |
103,004
+4,736
| +5% | +$74K |
|
2040
Twin Disc
TWIN
$355M
| $1.55M | ﹤0.01% |
131,193
+32,673
| +33% | +$484K |
|
2041
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.6B
| $1.54M | ﹤0.01% |
37,200
+21,400
| +135% | +$892K |
|
|
PPIH
2042
Perma-Pipe International
PPIH
$216M
| $1.54M | ﹤0.01% |
173,412
+3,119
| +2% | +$26.6K |
|
2043
Blend Labs
BLND
$331M
| $1.54M | ﹤0.01% |
653,660
-90,000
| -12% | -$239K |
|
2044
Amylyx Pharmaceuticals
AMLX
$2.6B
| $1.54M | ﹤0.01% |
811,488
+106,888
| +15% | +$207K |
|
2045
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.88B
| $1.54M | ﹤0.01% |
12,500
-2,900
| -19% | -$351K |
|
2046
Zedge
ZDGE
$38.6M
| $1.54M | ﹤0.01% |
505,014
+14,404
| +3% | +$38.8K |
|
2047
Acushnet Holdings
GOLF
$5.2B
| $1.54M | ﹤0.01% |
24,200
+18,300
| +310% | +$1.17M |
|
|
NTST
2048
NETSTREIT Corp
NTST
$2.08B
| $1.54M | ﹤0.01% |
95,400
-163,200
| -63% | -$2.81M |
|
2049
Ligand Pharmaceuticals
LGND
$5.76B
| $1.53M | ﹤0.01% |
18,200
-28,900
| -61% | -$2.3M |
|
2050
Nucor
NUE
$61.7B
| $1.53M | ﹤0.01% |
9,700
+400
| +4% | +$69.5K |
|
Similar funds
Jim Simons's Q2 2024 Portfolio in Review
As of Q2 2024, Jim Simons held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $4.49B in Q2 2024, closing 674 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Broadcom worth $472M.
- Jim Simons's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Jim Simons added most to Apple in Q2 2024, an estimated $244M increase.
- Jim Simons's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Jim Simons fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Jim Simons's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Jim Simons opened 463 new positions and closed 674 in Q2 2024.
- Jim Simons's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.